Mirikizumab
- 商品名称： Mirikizumab
详情描述
- 产品描述
-
产品参数
产品货号 XC978996-100µg 英文名称 Mirikizumab 中文名称 米吉珠单抗 抗体来源 Human 克隆类型 Monoclonal 性 状 Liquid 浓 度 1mg/mL 亚 型 IgG4κ 表达系统 CHO-K1 stable cell line 纯化方法 Affinity purified by Protein A 缓 冲 液 0.2 μm filtered in PBS, pH 7.4, 10% glycerol 纯 度 ＞98% as determined by SDS-PAGE；＞98% as determined by SEC-HPLC 保存条件
Aliquot and store at -20°C to -80°C,Avoid repeat freeze-thaw cycles.
注意事项
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍
Mirikizumab is a humanized anti-IL -23p19 IgG4 monoclonal antibody developed as a treatment for ulcerative colitis (UC) and Crohn’s disease. It targets interleukin-23 (IL-23) and binds to the p19 subunit of IL-23, a cytokine that plays a key role in promoting inflammation in autoimmune diseases. By inhibiting the binding of IL-23 to IL-23R, Mirikizumab helps reduce the inflammatory response, which is central to conditions like ulcerative colitis and Crohn's disease.
文件资料
关键词：
对照药 | 抗药抗体 | 仪器 | 试剂
相关产品
欢迎您的留言咨询
订阅信息
我们将定时给您发送实时资讯！
手机官网
微信公众号